Literature DB >> 18155756

Effects on spontaneous and cocaine-induced behavior of pharmacological inhibition of noradrenergic and serotonergic systems.

Robert J Carey1, Gail DePalma, Arielle Shanahan, Ernest N Damianopoulos, Christian P Müller, Joseph P Huston.   

Abstract

Cocaine-induced increases in dopamine (DA) contribute importantly to cocaine effects on behavior but, the role of concomitant increases in norepinephrine (NE) and serotonin (5-HT) is less well understood. In order to selectively block the increases in NE and 5-HT evoked by cocaine, autoreceptor preferring low doses (0.01, 0.025 and 0.05 mg/kg) of the a2 agonist, Clonidine or the 5-HT1A agonist, 8-OHDPAT were given as pretreatments 20 min prior to saline or cocaine (10.0 mg/kg) in separate groups of rats (N=10). With pharmacological stimulation of NE and 5-HT autoreceptors, release of these neurotransmitters would be suppressed and, therefore, less available for re-uptake blockade by cocaine. With increasing dose levels, Clonidine had marked inhibitory effects on spontaneous and cocaine-induced locomotion, grooming and rearing. 8-OHDPAT pretreatment also suppressed spontaneous locomotion, grooming and rearing; but, in contrast, did not reduce the cocaine locomotor stimulant effects. 8-OHDPAT, however, did suppress central zone entry and rearing in cocaine treated rats. Using ex vivo methods, we found that 8-OHDPAT selectively reduced 5-HT metabolism in the medial frontal cortex (MFC) and subcortical limbic brain. Clonidine selectively reduced NE metabolism in the MFC, but decreased both DA and 5-HT metabolism in the subcortical limbic brain without affecting NE metabolism. This diverse and broad spectrum of Clonidine effects upon neurotransmitters and behavior is striking and points-up the important, complex and integrative role of NE in brain function. While both Clonidine and 8-OHDPAT can substantially attenuate a number of cocaine behavioral effects, these inhibitory effects appear to be secondary to reductions in the behavioral baseline rather than reversals of cocaine effects.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18155756     DOI: 10.1016/j.pbb.2007.11.003

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  9 in total

1.  Cocaine conditioning: reversal by autoreceptor dose levels of 8-OHDPAT.

Authors:  Robert J Carey; Ernest N Damianopoulos; Arielle B Shanahan
Journal:  Pharmacol Biochem Behav       Date:  2008-09-09       Impact factor: 3.533

2.  α- and β-Adrenergic receptors differentially modulate the emission of spontaneous and amphetamine-induced 50-kHz ultrasonic vocalizations in adult rats.

Authors:  Jennifer M Wright; May R S Dobosiewicz; Paul B S Clarke
Journal:  Neuropsychopharmacology       Date:  2011-10-26       Impact factor: 7.853

3.  Assessment of safety, cardiovascular and subjective effects after intravenous cocaine and lofexidine.

Authors:  R De La Garza; G P Galloway; T F Newton; J Mendelson; C N Haile; E Dib; R Y Hawkins; C-Y A Chen; J J Mahoney; J Mojsiak; G Lao; A Anderson; R Kahn
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2013-12-04       Impact factor: 5.067

4.  Parallel declines in cognition, motivation, and locomotion in aging mice: association with immune gene upregulation in the medial prefrontal cortex.

Authors:  Kelly A Bordner; Robert R Kitchen; Becky Carlyle; Elizabeth D George; Milind C Mahajan; Shrikant M Mane; Jane R Taylor; Arthur A Simen
Journal:  Exp Gerontol       Date:  2011-03-29       Impact factor: 4.032

5.  Blockade of the 5-HT transporter contributes to the behavioural, neuronal and molecular effects of cocaine.

Authors:  Linda D Simmler; Allison M J Anacker; Michael H Levin; Nina M Vaswani; Paul J Gresch; Alex G Nackenoff; Noelle C Anastasio; Sonja J Stutz; Kathryn A Cunningham; Jing Wang; Bing Zhang; L Keith Henry; Adele Stewart; Jeremy Veenstra-VanderWeele; Randy D Blakely
Journal:  Br J Pharmacol       Date:  2017-07-11       Impact factor: 8.739

6.  Interaction between noradrenaline and corticotrophin-releasing factor in the reinstatement of cocaine seeking in the rat.

Authors:  Zenya J Brown; Erin Tribe; Nicole A D'souza; Suzanne Erb
Journal:  Psychopharmacology (Berl)       Date:  2008-11-05       Impact factor: 4.530

7.  Corticostriatal dysfunction underlies diminished striatal ascorbate release in the R6/2 mouse model of Huntington's disease.

Authors:  Jenelle L Dorner; Benjamin R Miller; Emma L Klein; Alexander Murphy-Nakhnikian; Rachel L Andrews; Scott J Barton; George V Rebec
Journal:  Brain Res       Date:  2009-07-16       Impact factor: 3.252

8.  Interference of norepinephrine transporter trafficking motif attenuates amphetamine-induced locomotor hyperactivity and conditioned place preference.

Authors:  Padmanabhan Mannangatti; Sammanda Ramamoorthy; Lankupalle Damodara Jayanthi
Journal:  Neuropharmacology       Date:  2017-10-04       Impact factor: 5.250

9.  Prenatal Cocaine Disrupts Serotonin Signaling-Dependent Behaviors: Implications for Sex Differences, Early Stress and Prenatal SSRI Exposure.

Authors:  Sarah K Williams; Jean M Lauder; Josephine M Johns
Journal:  Curr Neuropharmacol       Date:  2011-09       Impact factor: 7.363

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.